Ichiro Nakamura et al <br/><br/>
Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works